Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice
Qing Ding, Melissa Yeung, Geoffrey Camirand, Qiang Zeng, Hisaya Akiba, Hideo Yagita, Geetha Chalasani, Mohamed H. Sayegh, Nader Najafian, David M. Rothstein
Qing Ding, Melissa Yeung, Geoffrey Camirand, Qiang Zeng, Hisaya Akiba, Hideo Yagita, Geetha Chalasani, Mohamed H. Sayegh, Nader Najafian, David M. Rothstein
View: Text | PDF
Research Article Immunology

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice

  • Text
  • PDF
Abstract

T cell Ig domain and mucin domain protein 1 (TIM-1) is a costimulatory molecule that regulates immune responses by modulating CD4+ T cell effector differentiation. However, the function of TIM-1 on other immune cell populations is unknown. Here, we show that in vivo in mice, TIM-1 is predominantly expressed on B rather than T cells. Importantly, TIM-1 was expressed by a large majority of IL-10–expressing regulatory B cells in all major B cell subpopulations, including transitional, marginal zone, and follicular B cells, as well as the B cell population characterized as CD1dhiCD5+. A low-affinity TIM-1–specific antibody that normally promotes tolerance in mice, actually accelerated (T cell–mediated) immune responsiveness in the absence of B cells. TIM-1+ B cells were highly enriched for IL-4 and IL-10 expression, promoted Th2 responses, and could directly transfer allograft tolerance. Both cytokine expression and number of TIM-1+ regulatory B cells (Bregs) were induced by TIM-1–specific antibody, and this was dependent on IL-4 signaling. Thus, TIM-1 is an inclusive marker for IL-10+ Bregs that can be induced by TIM-1 ligation. These findings suggest that TIM-1 may be a novel therapeutic target for modulating the immune response and provide insight into the signals involved in the generation and induction of Bregs.

Authors

Qing Ding, Melissa Yeung, Geoffrey Camirand, Qiang Zeng, Hisaya Akiba, Hideo Yagita, Geetha Chalasani, Mohamed H. Sayegh, Nader Najafian, David M. Rothstein

×

Figure 4

IL-4 and IL-10 are expressed by TIM-1+ B cells and induced by TIM-1 ligation.

Options: View larger image (or click on image) Download as PowerPoint
IL-4 and IL-10 are expressed by TIM-1+ B cells and induced by TIM-1 liga...
Splenic CD19+ B cells from BALB/c mice were naive, transplanted with B6 islets, or transplanted and treated with anti–TIM-1 or control Ig on day 14. (A) IL-4 and IL-10 expression, gated on CD19+ B cells (control and total B cells) or on TIM-1– and TIM-1+ B cells. IL-4 (EGFP) versus control (WT littermates); IL-10 (intracellular staining) versus control (isotype). (B) Frequency (mean + SD) of B cells expressing cytokines from mice in A. *P < 0.05 vs. naive; #P < 0.05 vs. all other groups. (C) Frequency (mean + SD) of cytokine expression on TIM-1– versus TIM-1+ B cells from anti–TIM-1–treated allograft recipients. *P < 0.01 vs. TIM-1–. (D) TIM-1 expression (mean + SD) on B, CD4+ T, and CD8+ T cells. *P < 0.05 vs. naive; #P < 0.05 vs. all other groups. (E) Total number (mean + SD) of splenic B and CD4+ T cells. (A–E) n ≥ 5 mice/group in at least 3 experiments. (F and G) Sorted TIM-1– “index” B cells (see Methods) from naive BALB/c mice were transferred into syngeneic JHD (F) or RAG2-KO (G) mice. Recipients were naive or were exposed to alloantigen (allograft or allogeneic splenocytes) with or without anti–TIM-1 or control Ig. TIM-1 expression on index B cells recovered from spleen (day 14) is shown in representative dot plots (F), or as frequency (G; mean + SD). n = 3 mice/group. *P < 0.05 vs. no allograft; #P < 0.01 vs. all other groups. Numbers denote percent cells in the respective quadrants.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts